The present invention relates to biologic tissues, which are used to create cellular matrix scaffolds to help repair the body. The invention discloses two specific implant shapes that are pre-cut to address two separate pelvic floor prolapses (anterior and/or posterior). Additionally, the method of providing surgeries-specific pre-shaped biologic scaffolds is also claimed.

Extra-urethral implants and methods of use are disclosed. Implants can treat disorders or diseases of the prostate by, for example, enlarging the lumen of the prostatic urethra.

Extra-urethral implants and methods of use are disclosed. Implants can treat disorders or diseases of the prostate by, for example, enlarging the lumen of the prostatic urethra.

A uterine manipulator device includes: an elongated cannulated tube having proximal and distal ends, a cervical cup positioned on the elongated cannulated tube with a top distal portion of a first diameter and a base proximal portion of a second smaller diameter, and a balloon occluder assembly. The balloon occluder assembly can be used independently or positioned proximally from the cervical cup on the elongated cannulated tube.

A fallopian tube access system includes an outer tube assembly including an outer tube and a sleeve extending distally from the outer tube, and an inner tube assembly including an inner tube and an expander extending distally from the inner tube. The inner tube assembly is positioned within the outer tube assembly such that the expander is located within the sleeve in a compressed state. The outer tube assembly is movable relative to the inner tube assembly to expose the expander and transition the expander from the compressed state to an expanded state.

A fallopian tube access system includes an outer tube assembly including an outer tube and a sleeve extending distally from the outer tube, and an inner tube assembly including an inner tube and an expander extending distally from the inner tube. The inner tube assembly is positioned within the outer tube assembly such that the expander is located within the sleeve in a compressed state. The outer tube assembly is movable relative to the inner tube assembly to expose the expander and transition the expander from the compressed state to an expanded state.

Provided are a treatment apparatus and a treatment method capable of effectively treating cancer tumor cell (for example cancer in a range including at least a part of a cervix). A treatment apparatus is configured to irradiate an antibody-photosensitive substance bound to a tumor cell with excitation light, and includes: a main shaft including a distal portion and a proximal portion; a distal structure portion disposed on a distal side of the main shaft and formed to be larger than the main shaft in a radial direction of the main shaft; a distal shaft protruding from the distal structure portion toward the distal side; and at least one irradiation unit configured to emit the excitation light of the antibody-photosensitive substance from the distal shaft and the distal structure portion.

A treatment apparatus and a treatment method capable of effectively treating cancer in a range including at least a part of a cervix. A treatment apparatus is configured to irradiate an antibody-photosensitive substance accumulated in a tumor cell with excitation light, and includes: a tubular device including an elongated tubular member; and an irradiation device configured to be inserted into the tubular member. The irradiation device includes a main shaft including a distal portion and a proximal portion, a disk portion disposed on a distal side of the main shaft, a distal shaft protruding from the disk portion toward the distal side, and an irradiation unit disposed on the distal shaft and configured to emit the excitation light.

A hysteroscopic fluid management system includes a saline source with an electrolyte concentration, at least one pressure mechanism for circulating saline to and from a targeted site and through a filter having filter characteristics back to the source, and a controller. The controller provides a saline inflow in a first flow path to the site and a saline outflow in a second flow path from the site through the filter and back to the source at a controlled flow rate. A diagnostic or therapeutic procedure is performed at the site in the presence of the saline. The filter characteristics and the controlled flow rate are selected to (1) cause substantially no change in the electrolyte concentration in the saline, (2) to prevent hemolysis of greater than 5% of filtered red blood cells exposed to the saline, and/or (3) to minimize effect on prothrombin time of plasma exposed to the filter.

The Cervical Dilator is an improved tool for dilating a woman’s cervix prior to gynecological surgeries. The Cervical Dilator comprises a solid dilator with a first diameter and a series of hollow dilators. The series of hollow dilators comprises a plurality of hollow dilators of increasing size. A first hollow dilator has a second diameter that may be 1 mm larger than the first diameter. A second hollow dilator has a third diameter that may be 1 mm larger than the second diameter. A third hollow dilator has a fourth diameter that may be 1 mm larger than the third diameter. Thereby, upon insertion of the next hollow dilator in the series, the dilation of the cervix is increases by 1 mm.